封面
市场调查报告书
商品编码
1208612

2023-2030 年全球眼科诊断设备市场

Global Ophthalmic Diagnostic Equipment Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球眼科诊断设备市场预计到 2023 年将达到 45 亿美元,到 2030 年将达到 64 亿美元,在预测期内(2023-2030 年)以 5.4% 的复合年增长率增长。 .

眼科诊断设备是指用于诊断青光眼、糖尿病相关性视网膜病变、老年性黄斑变性等眼科疾病的设备。 通过使用该设备,眼科医生可以大大提高诊断的准确性,提高诊断效率。

市场动态

推动全球眼科诊断设备市场的主要因素是由于青光眼、年龄相关性黄斑变性和白内障等视力障碍发病率的增加、意识改革的努力以及新产品以及在手术过程中保护眼睛的需求日益增加。

手术期间保护眼睛的需求日益增长,技术进步导致新设备的开发预计将推动市场增长。

眼科诊断设备市场受到技术进步、人口老龄化、研发投入快速增加、青光眼、白内障、糖尿病性黄斑水肿、AMD等眼病增加以及对新产品需求增加的推动使用最新技术的产品,改进和改善新兴市场的医疗保健基础设施。

眼科诊断设备广泛用于手术和治疗。 这些电器和设备的越来越多的采用导致政府加大了努力和资金投入。 这些资金将用于眼科超声机、眼压计、裂隙灯等眼科诊断设备产品的生产。 由于眼科疾病的增加,这些仪器和设备的市场正在全球范围内扩大。 此外,预计主要製造商提供的先进产品也将在市场增长中发挥重要作用。

与这些用于诊断和治疗的眼科诊断设备相关的各种新产品发布、研究和提高认识活动的兴起有助于市场的增长。 例如,2022 年 4 月 1 日,Ziemer Ophthalmic Systems 宣布 FDA 批准了一种新的飞秒激光器 FEMTO Z8 NEO,以取代其专有的 LDV Z8 多用途飞秒激光器。 FEMTO Z8 NEO 提供先进的硬件以及新的和改进的软件应用程序。 新开发的平台显着提高了可用性、性能和患者舒适度。 新的激光源和监控系统优化了可靠性和准确性。

由于产品中所含器官的敏感性,高风险预计会阻碍市场增长。

严格的眼科诊断设备审批规则和法规是阻碍眼科诊断设备市场增长的主要因素。 必须满足各种要求和临床试验,从而增加了这些设备的总成本。

此外,由于产品中所含器官的高敏感性以及缺乏经验丰富的专业人员来妥善处理这些设备而导致的高风险也是限制市场增长的主要因素。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 眼科诊断设备市场因 COVID 遭受了巨大损失。 主要製造商已经启动了各种研究和临床试验。 世界各地正在开展各种举措、产品发布、合作和合併,以促进市场的增长。 例如,2021 年 5 月 19 日,Glaukos Corporation 收购了 Santen Pharmaceutical Co., Ltd.,用于在澳大利亚、美洲(北美洲、中美洲和南美洲)和新西兰开发、营销和分销 Santen 拥有的 STN2000100 手术设备(“ DE-128”). Ltd. 宣布结束扩大合作关係。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 手术期间对眼睛保护的需求不断增长
      • 技术进步激增
      • 视障人士人数增加
    • 约束因素
      • 产品中含有敏感器官的风险
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 折光仪
  • 光学相干断层扫描
  • 眼科超声诊断设备
  • 眼压计
  • 裂隙灯
  • 角膜地形图系统
  • 检眼镜
  • 眼底照相机
  • 镜头计
  • 其他

第八章应用

  • 白内障
  • 青光眼
  • 年龄相关性黄斑变性
  • 糖尿病性黄斑水肿
  • 其他

第 9 章最终用户

  • 医院
  • 眼科诊所
  • 门诊手术中心
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • 豪迈集团
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Coburn Technologies, Inc.
  • Ellex
  • Nidek Co., Ltd.
  • Kowa American Corporation
  • Quantel Medical
  • Topcon Corporation
  • ZEISS Group
  • Haag-Streit Group
  • Ziemer Ophthalmic Systems AG

第13章 DataM

简介目录
Product Code: DMMD98

Market Overview

The global ophthalmic diagnostic equipment market size was valued at US$ 4.5 billion in 2023 and is estimated to reach US$ 6.4 billion by 2030, growing at a CAGR of 5.4% during the forecast period (2023-2030).

Ophthalmic diagnostic equipment refers to the equipment utilized for the diagnosis of ophthalmic conditions such as glaucoma, diabetes-related retinopathy, age-related macular degeneration, and more. With this equipment, ophthalmologists can greatly enhance their accuracy while improving their efficiency.

Market Dynamics

The major factors driving the global ophthalmic diagnostic equipment market are the rising demand for ophthalmic diagnostic equipment owing to increasing incidences of visual impairment such as glaucoma, age-related macular degeneration and cataract, surging awareness initiatives, advancements in technologies leading to the development of novel products and rising need to protect the eyes during surgeries.

The rising need to protect the eyes during surgeries and rising technological advancements leading to the development of new equipment are expected to drive the market's growth.

The ophthalmic diagnostic equipment market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ophthalmic disorders such as glaucoma, cataract, diabetic macular edema, AMD and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The ophthalmic diagnostic equipment and devices are being used widely for surgeries or treatment purpose. The adoption of these equipment or devices is increasing, leading to rising government initiatives and funds. These funds will help produce ophthalmic diagnostic equipment products such as ophthalmic ultrasound devices, tonometers or slit lamp. The market for these equipment or devices is increasing worldwide due to the enhanced number of these ophthalmic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these ophthalmic diagnostic equipment for diagnosis and treatment contribute to the market's growth. For instance, in April 1, 2022, Ziemer Ophthalmic Systems announced about received clearance by FDA for the FEMTO Z8 NEO, its novel femtosecond laser, the successor of the unique LDV Z8 Multipurpose Femtosecond Laser. The FEMTO Z8 NEO offers advanced hardware along with novel improved software applications. The newly developed platform provides substantial improvements on usability, performance and patient comfort. Reliability and precision were optimized by a novel laser source or monitoring system.

High risks involved due to the sensitivity of the organ in the product are expected to hamper the market's growth.

Strict rules and regulations for the approval of equipment utilized for ophthalmic diagnostic is the major factor hindering the growth of the ophthalmic diagnostic equipment market. Various requirements, clinical trials must be fulfilled, leading to an increase in the overall cost of these equipment.

High risk related due to the sensitivity of the organ in the product and the lack of experienced professionals for proper handling of these equipment devices is also a key factor limiting market's growth.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The ophthalmic diagnostic equipment market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in May 19, 2021, Glaukos Corporation announced about entering into an expanded collaboration with the Santen Pharmaceutical Co., Ltd. for the Santenowned STN2000100 surgical device ("DE-128") development, marketing, and sales in the Australia, Americas (North, Central, and South America) and New Zealand.

Segment Analysis

The optical coherence tomography segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The optical coherence tomography segment is the highest market holder in the global ophthalmic diagnostic equipment market. The global ophthalmic diagnostic equipment market is segmented based on product type as refractometers, optical coherence tomography, ophthalmic ultrasound devices, tonometers, slit lamp, corneal topography systems, ophthalmoscope, fundus camera, lensometers and others. The optical coherence tomography segment is the largest market shareholder due to the increasing number of visual impairments incidences globally, increasing technological advancements and novel product launches.

Optical coherence tomography (OCT) is the most commonly used ophthalmic diagnostic equipment. Optical coherence tomography is a non-invasive imaging procedure which utilizes reflected light and produce pictures of the retina, back of the eye. OCT can be utilized for diagnosis and management of diseases such as glaucoma and diabetes-related retinopathy. This method creates an image by evaluating the dim red light's amount which reflects off of the optic nerve and retina. OCT can evaluate the thickness of optic nerve and retina. The ophthalmologists use OCT angiography to have a look inside the blood vessels present in the eye.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, on May 25, 2022, Ziemer Ophthalmology launched the novel upgrades of the GALILEI G6 Toric IOL Calculator and Barrett Formula taking the refractive cataract surgery planning to next level. The GALILEI G6 provides extensive, up-to-date calculator and formulas software packages, creating its full capability as all-in-one diagnostic equipment integrating dual scheimpflug tomography with optical biometry and Placido topography.

Geographical Analysis

North America holds the largest market share in the global ophthalmic diagnostic equipment market.

North America dominates the global ophthalmic diagnostic equipment market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of ophthalmic diagnostic equipment in several ophthalmic conditions like glaucoma, age-related macular degeneration or cataract, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the ophthalmic diagnostic equipment market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in August 31, 2021, Santen Pharmaceutical Co., Ltd., a specialized ophthalmology company announced its strategic partnership with Shanghai Airdoc Medical Technology Co., Ltd., a retina artificial intelligence enterprise to enhance eye disease diagnostic rate and improve eye health level among communities of China. Santen will provide full play to its extensive channels in ophthalmology to commercialize portable fundus camera to concerned departments in medical institutions in China, and to offer Chinese grassroots medical system with accurate, fair-price, fine, and guaranteed fundi screening devices with supporting solutions.

Competitive Landscape

The ophthalmic diagnostic equipment market is highly competitive with local and global companies' presence. Halma Plc, Coburn Technologies, Inc., Ellex, Nidek Co., Ltd., Kowa American Corporation, Quantel Medical, Topcon Corporation, ZEISS Group, Haag-Streit Group, Ziemer Ophthalmic Systems AG, and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 1, 2021, Ziemer, a laser diagnostics and eye care provider announced its strategic alliance with Zubisoft to introduce lens calculation and laser nomogram technologies in the market. Zubisoft GmbH is the IBRA digital health suite manufacturer, a treatment planning or outcome system for refractive and cataract surgery.

Halma Plc

Overview: Halma Plc is a life-saving technology companies group that consists of 44 businesses regulated in a decentralized manner. Halma, via its products, is focused on trying to make the world cleaner, safer and healthier. This group operates in three segments: environmental and analysis, safety, and medical equipment.

Product Portfolio:

4 Sight: For ophthalmic diagnostics, it provides a single solution by combining a Pachymeter, A-Scan, B-Scan, and UBM in one, easy-to-utilize platform.

Key Development: In June 8, 2022, Keeler, part of Halma supported the Vision 2020 LINKS Programme and donated a slit lamp to Dominica. The laser unit in Dominica broke down which now is replaced by this latest Keeler slit lamp.

The global ophthalmic diagnostic equipment market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising need to protect the eyes during surgeries
      • 4.1.1.2. Surge in technological advancements
      • 4.1.1.3. Increasing cases of visual impairment
    • 4.1.2. Restraints:
      • 4.1.2.1. Risks involved due to the sensitivity of the organ in the product
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Refractometer *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Optical Coherence Tomography
  • 7.4. Ophthalmic Ultrasound Devices
  • 7.5. Tonometers
  • 7.6. Slit Lamp
  • 7.7. Corneal Topography Systems
  • 7.8. Ophthalmoscope
  • 7.9. Fundus Camera
  • 7.10. Lensometers
  • 7.11. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cataract *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Glaucoma
  • 8.4. Age-related Macular Degeneration
  • 8.5. Diabetic Macular Edema
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ophthalmic Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Halma Plc *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Coburn Technologies, Inc.
  • 12.3. Ellex
  • 12.4. Nidek Co., Ltd.
  • 12.5. Kowa American Corporation
  • 12.6. Quantel Medical
  • 12.7. Topcon Corporation
  • 12.8. ZEISS Group
  • 12.9. Haag-Streit Group
  • 12.10. Ziemer Ophthalmic Systems AG

LIST NOT EXHAUSTIVE

13. Global Ophthalmic Diagnostic Equipment Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Medications
  • 13.3. Contact Us